Transplant
Phase I/II study of the adjunctive use of Nilotinib in patients undergoing reduced intensity allogeneic transplantation for Imatinib resistant or intolerant Chronic Myeloid Leukaemia.
Tasigna in reduced intensity conditioning transplantation evaluation study.
A phase III randomised study to investigate the use of adoptive cellular therapy (ACT) in combination with conventional antiviral drug therapy for the treatment of CMV reactivation episodes in patients following allogeneic haematopoietic stem cell transplant
TRANSPLANTATION OF UMBILICAL CORD BLOOD FROM UNRELATED DONORS IN PATIENTS WITH HAEMATOLOGICAL DISEASES USING A REDUCED INTENSITY CONDITIONING REGIMEN